Zobrazeno 1 - 10
of 40
pro vyhledávání: '"anti-obesity pharmacotherapy"'
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Type 2 diabetes mellitus (T2DM) in adolescents is a more rapidly progressive disease, associated with earlier and higher rates of microvascular complications than in adults. As obesity is a significant risk factor for T2DM development and progression
Externí odkaz:
https://doaj.org/article/124587849f2f456cb0d65ee84082addf
Autor:
Sarah R. Barenbaum, Sherin E. Mathews, Katherine H. Saunders, Guadalupe Minero, Elizabeth Mauer, Louis J. Aronne, Alpana P. Shukla
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 2, Pp 134-138 (2020)
Summary Background BMIQ is a customizable online platform used to deliver evidence‐based behavioural management that complements office visits with healthcare providers. BMIQ offers educational materials, meal plans and tracking tools for patients,
Externí odkaz:
https://doaj.org/article/2a1d52b191ec4bf1ae33b00edaff0429
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
FDA approved anti-obesity medications may not be cost effective for patients struggling with pre-operative weight loss prior to bariatric surgery. Metformin, a biguanide, and Topiramate, a carbonic anhydrase inhibitor, both cost effective medications
Externí odkaz:
https://doaj.org/article/ba5eee0bb0914c48ab41924a365d7cd2
Autor:
Katherine H. Saunders, Sherin E Mathews, Elizabeth Mauer, Alpana P. Shukla, Sarah R Barenbaum, Louis J. Aronne, Guadalupe Minero
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 2, Pp 134-138 (2020)
Obesity Science & Practice
Obesity Science & Practice
Summary Background BMIQ is a customizable online platform used to deliver evidence‐based behavioural management that complements office visits with healthcare providers. BMIQ offers educational materials, meal plans and tracking tools for patients,
Autor:
Alexander T. Toth, Gricelda Gomez, Alpana P. Shukla, Janey S. Pratt, Hellas Cena, Ginevra Biino, Louis J. Aronne, Fatima Cody Stanford
Publikováno v:
Children, Vol 5, Iss 9, p 116 (2018)
This paper presents a retrospective cohort study of weight loss medications in young adults aged 21 to 30 following Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between November 2000 and June 2014. Data were collected from patients who
Externí odkaz:
https://doaj.org/article/e616dc12ab5a45a6ac2809997bdcbc4a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Endocrinology
FDA approved anti-obesity medications may not be cost effective for patients struggling with pre-operative weight loss prior to bariatric surgery. Metformin, a biguanide, and Topiramate, a carbonic anhydrase inhibitor, both cost effective medications
Publikováno v:
Romanian Journal of Diabetes Nutrition and Metabolic Diseases, Vol 23, Iss 4, Pp 415-422 (2016)
Background and Aims: In the last three decades, obesity and its related co morbidities has quickly increased. Sometime, obesity was viewed as a serious health issue in developed countries alone, but now is recognized as a worldwide epidemic, and its